Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
national blog main
aging in place
ali ahmadi
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
cbo
centers for medicare and medicaid services
clinical trials
cms
congressional budget office
deals
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
gener8tor
healthcare
joshua brumm
kaiser permanente
kaleido biosciences
life sciences
medicaid
medicare
muscular dystrophy
myotonic dystrophy type 1
national top stories
new york blog main
rare disease drugs
rhonda montgomery
romesh subramanian
san diego blog main
san francisco blog main
seattle blog main
What
data
2
×
expected
2
×
according
account
ago
aids
baby
biotechs
boomers
budget
congressional
considering
costs
diseases
domestic
double
drug
dyne
early
experimental
eyes
genetic
gross
having
humans
iceberg
industry
ipo
ipos
live
long
loved
medicaid
medicare
medicines
muscle
office
ones
people
percent
Language
unset
Current search:
expected
×
photo
×
data
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
Tcare’s Software Aids People Who Live with, and Care for, Loved Ones
